Skip to main content

Table 1 Characteristics of the participants at baseline*

From: A retrospective study of estrogen in the pretreatment for medical management of early pregnancy loss and the inference from intrauterine adhesion

Project

Mifepristone and estradiol valerate-pretreatment group (N = 72)

Estradiol valerate-pretreatment group (N = 58)

Mifepristone-pretreatment group (N = 56)

Methylate carboprost suppository-alone group (N = 40)

P

Maternal age, mean ± SD

31.63 ± 4.32

30.91 ± 5.52

30.98 ± 5.41

31.13 ± 3.82

0.8316

Gestational weeks, mean ± SD

9.85 ± 1.25

9.81 ± 1.54

9.82 ± 1.62

9.88 ± 1.34

0.9943

Previous early pregnancy loss times, mean ± SD

0.57 ± 0.85

0.45 ± 0.82

0.29 ± 0.56

0.25 ± 0.44

0.1182

Previous induced abortion tines, mean ± SD

0.6 ± 0.78

0.76 ± 0.84

0.54 ± 0.85

0.4 ± 0.67

0.0784

MSD, mean ± SD

24.15 ± 9.33

25.82 ± 9.42

22.17 ± 11.29

24.74 ± 8.89

0.2516

Parity, mean ± SD

0.39 ± 0.52

0.4 ± 0.56

0.61 ± 0.68

0.3 ± 0.52

0.0895

IUA, n(%)

28 (38.89%)

20 (34.48%)

14 (25.00%)

9 (22.50%)

0.198

  1. IUA: Intrauterine adhesion; MSD: Mean sac diameter; SD: standard deviation
  2. *Plus–minus values are means ± SD. There were no significant differences between the groups in any of the characteristics listed. Percentages may not sum to 100 because of rounding
Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us